Clinical Trial Update: A Prospective Natural History Study of Progression of Subjects With Duchenne Muscular Dystrophy.

View source ↗

Summary

A prospective natural history study of Duchenne Muscular Dystrophy sponsored by BioMarin has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Snippet

Sponsor: BioMarin Pharmaceutical | Conditions: Duchenne Muscular Dystrophy | Status: TERMINATED